Trial intelligence / Profile preview

IPERGAY: On-Demand Truvada PrEP for HIV Prevention

NCT01473472Phase 3Completed

Sponsor
ANRS
Start
Jan 2012
Primary completion
Jun 2016
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by ANRS. Started Jan 2012; status: completed.

02

Drugs

emtricitabine + tenofovir disoproxil
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT01473472.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01473472.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call